Online citations, reference lists, and bibliographies.
← Back to Search

Vandetanib Plus Docetaxel Versus Docetaxel As Second-line Treatment For Patients With Advanced Non-small-cell Lung Cancer (ZODIAC): A Double-blind, Randomised, Phase 3 Trial

Roy S Herbst, Yan Sun, Wilfried EE Eberhardt, Paul Germonpré, Nagahiro Saijo, Caicun Zhou, Jie Wang, Longyun Li, Fairooz Kabbinavar, Yukito Ichinose, Shukui Qin, Li Zhang, Bonne Biesma, John V Heymach, Peter Langmuir, Sarah J Kennedy, Hiroomi Tada, Bruce E Johnson

Save to my Library
Download PDF
Analyze on Scholarcy
Share